Patent classifications
A23V2200/31
FAST-DISSOLVING CO-CRYSTALLINE LACTOSE
The invention relates to nutritional compositions comprising lactose.calcium salt co-crystals and to the use of these co-crystals for preparing nutritional compositions, as carrier, filler or stabilizer, for accelerating lactose dissolution as well as for efficient calcium fortification of compositions. Furthermore, the present invention is directed to a process for preparing such lactose.calciumsalt co-crystals and nutritional compositions comprising such.
ANTI-FATIGUE FOOD COMPOSITION AND ANTI-FATIGUE AGENT
Problems
To provide an anti-fatigue food composition exerting an anti-fatigue effect in the form of food to be ingested easily.
Means for solving the problems
An anti-fatigue food composition containing an aged garlic extract aged by heating.
ANTI-FATIGUE FOOD COMPOSITION AND ANTI-FATIGUE AGENT
Problems
To provide an anti-fatigue food composition exerting an anti-fatigue effect in the form of food to be ingested easily.
Means for solving the problems
An anti-fatigue food composition containing an aged garlic extract aged by heating.
GEL COMPOSITION AND METHOD FOR MANUFACTURING SAME
The present invention addresses the problem of providing a gel composition, which comprises a large amount of a fat or an oil containing medium-chain fatty acids in the constituting fatty acids thereof, shows no separation of the fat or oil and relieves gastric distress when eating, and a method for manufacturing the same. The gel composition according to the present invention, which is a gel composition prepared by gelling an oil-in-water type emulsion having an average emulsified particle size of 2-40 m, contains 20-60 mass % of triglycerides, wherein 40 mass % or more of the total constituting fatty acids of the triglycerides are medium-chain fatty acids. The triglycerides may comprise a medium-chain fatty acid triglyceride.
Compositions and methods for diagnosing susceptibility to autism spectrum disorder (ASD), reducing the likelihood of developing ASD, and/or treating ASD
The present invention provides compositions and methods for improving the quality of life for a subject, particularly a child, diagnosed with autism spectrum disorder (ASD). In preferred embodiments, a supplement composition comprising natural or naturally-derived ingredients is delivered to a subject in the form of a chocolate bar or other candy alongside administration of an antiviral medication. Advantageously, the composition and methods can improve the immune health of the subject, along with other signs and symptoms associated with ASD, infections and other immunocompromising conditions.
Compositions and methods for diagnosing susceptibility to autism spectrum disorder (ASD), reducing the likelihood of developing ASD, and/or treating ASD
The present invention provides compositions and methods for improving the quality of life for a subject, particularly a child, diagnosed with autism spectrum disorder (ASD). In preferred embodiments, a supplement composition comprising natural or naturally-derived ingredients is delivered to a subject in the form of a chocolate bar or other candy alongside administration of an antiviral medication. Advantageously, the composition and methods can improve the immune health of the subject, along with other signs and symptoms associated with ASD, infections and other immunocompromising conditions.
COMPOSITIONS AND METHODS OF TREATING VIRAL INFECTIONS
The present invention relates to the field of nutraceuticals, and in particular to nutraceuticals comprising sulfated polysaccharides, Astragalus polysaccharides, resveratrol, and combinations thereof. These compositions find use in inducing physiological responses such, decreasing body fat, increasing lean body mass, alleviating the symptoms of colds, preventing the onset of colds, increasing energy, increasing the feeling of well-being in subjects, and improving skin tone and appearance.
COMPOSITIONS AND METHODS OF TREATING VIRAL INFECTIONS
The present invention relates to the field of nutraceuticals, and in particular to nutraceuticals comprising sulfated polysaccharides, Astragalus polysaccharides, resveratrol, and combinations thereof. These compositions find use in inducing physiological responses such, decreasing body fat, increasing lean body mass, alleviating the symptoms of colds, preventing the onset of colds, increasing energy, increasing the feeling of well-being in subjects, and improving skin tone and appearance.
COMPOSITIONS PROVIDING EXTENDED ENERGY AND METHODS OF USE
Compositions that provide sustained energy up to 8 hours with an amount of caffeine that is less than 25 mg are described. The compositions comprise at least an astragaloside compound, a ginsenoside compound, a stilbenoid compound, and caffeine. Many of the compositions further comprise an amino acid having anabolic properties (e.g., having a role in the regulation of protein metabolism), including one or more of the group of arginine, ornithine, citrulline, glutamine, and a precursor, analog, prodrug, and/or derivative thereof, as well as molecules that interact with arginosuccinate synthase and/or arginosuccinate lyase, and analogs, prodrugs and derivatives thereof. Methods of utilizing the described compositions include administering orally to a subject an effective amount of the described composition, such that the composition provides sustained energy for up to 8 hours with an amount of caffeine in the composition administered orally that is less than 25 mg.
COMPOSITIONS PROVIDING EXTENDED ENERGY AND METHODS OF USE
Compositions that provide sustained energy up to 8 hours with an amount of caffeine that is less than 25 mg are described. The compositions comprise at least an astragaloside compound, a ginsenoside compound, a stilbenoid compound, and caffeine. Many of the compositions further comprise an amino acid having anabolic properties (e.g., having a role in the regulation of protein metabolism), including one or more of the group of arginine, ornithine, citrulline, glutamine, and a precursor, analog, prodrug, and/or derivative thereof, as well as molecules that interact with arginosuccinate synthase and/or arginosuccinate lyase, and analogs, prodrugs and derivatives thereof. Methods of utilizing the described compositions include administering orally to a subject an effective amount of the described composition, such that the composition provides sustained energy for up to 8 hours with an amount of caffeine in the composition administered orally that is less than 25 mg.